Literature DB >> 24261460

Risk factors for the progression of cystic fibrosis lung disease throughout childhood.

Don B Sanders1, Zhanhai Li, Anita Laxova, Michael J Rock, Hara Levy, Jannette Collins, Claude Ferec, Philip M Farrell.   

Abstract

RATIONALE: Previous studies of risk factors for progression of lung disease in cystic fibrosis (CF) have suffered from limitations that preclude a comprehensive understanding of the determinants of CF lung disease throughout childhood. The epidemiologic component of the 27-year Wisconsin Randomized Clinical Trial of CF Neonatal Screening Project (WI RCT) afforded us a unique opportunity to evaluate the significance of potential intrinsic and extrinsic risk factors for lung disease in children with CF.
OBJECTIVES: Describe the most important intrinsic and extrinsic risk factors for progression of lung disease in children with CF.
METHODS: Variables hypothesized at the onset of the WI RCT study to be determinants of the progression of lung disease and potential risk factors previously identified in the WI RCT study were assessed with multivariable generalized estimating equation models for repeated measures of chest radiograph scores and pulmonary function tests in the WI RCT cohort.
MEASUREMENTS AND MAIN RESULTS: Combining all patients in the WI RCT, 132 subjects were observed for a mean of 16 years and contributed 1,579 chest radiographs, and 1,792 pulmonary function tests. The significant determinants of lung disease include genotype, poor growth, hospitalizations, meconium ileus, and infection with mucoid Pseudomonas aeruginosa. The previously described negative effect of female sex was not seen.
CONCLUSIONS: Modifiable extrinsic risk factors are the major determinants of progression of lung disease in children with CF. Better interventions to prevent or treat these risk factors may lead to improvements in lung health for children with CF.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24261460      PMCID: PMC3972988          DOI: 10.1513/AnnalsATS.201309-303OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  67 in total

1.  Is there still a gender gap in cystic fibrosis?

Authors:  Nisha Verma; Andrew Bush; Roger Buchdahl
Journal:  Chest       Date:  2005-10       Impact factor: 9.410

2.  Wisconsin cystic fibrosis chest radiograph scoring system: validation and standardization for application to longitudinal studies.

Authors:  R E Koscik; M R Kosorok; P M Farrell; J Collins; M E Peters; A Laxova; C G Green; L Zeng; L S Rusakow; R C Hardie; P W Campbell; J W Gurney
Journal:  Pediatr Pulmonol       Date:  2000-06

3.  Evidence on improved outcomes with early diagnosis of cystic fibrosis through neonatal screening: enough is enough!

Authors:  Philip M Farrell; HuiChuan J Lai; Zhanhai Li; Michael R Kosorok; Anita Laxova; Christopher G Green; Jannette Collins; Gary Hoffman; Ronald Laessig; Michael J Rock; Mark L Splaingard
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

4.  Genetic modifiers of lung disease in cystic fibrosis.

Authors:  Mitchell L Drumm; Michael W Konstan; Mark D Schluchter; Allison Handler; Rhonda Pace; Fei Zou; Maimoona Zariwala; David Fargo; Airong Xu; John M Dunn; Rebecca J Darrah; Ruslan Dorfman; Andrew J Sandford; Mary Corey; Julian Zielenski; Peter Durie; Katrina Goddard; James R Yankaskas; Fred A Wright; Michael R Knowles
Journal:  N Engl J Med       Date:  2005-10-06       Impact factor: 91.245

Review 5.  Overview of published evidence on outcomes with early diagnosis from large US observational studies.

Authors:  Margaret Rosenfeld
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

Review 6.  Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe.

Authors:  Jeannette E Dankert-Roelse; Marieke E Mérelle
Journal:  J Pediatr       Date:  2005-09       Impact factor: 4.406

7.  Nutritional status of patients with cystic fibrosis with meconium ileus: a comparison with patients without meconium ileus and diagnosed early through neonatal screening.

Authors:  H C Lai; M R Kosorok; A Laxova; L A Davis; S C FitzSimmon; P M Farrell
Journal:  Pediatrics       Date:  2000-01       Impact factor: 7.124

8.  Cystic fibrosis mutations and genotype-pulmonary phenotype analysis.

Authors:  Andrew T Braun; Philip M Farrell; Claude Ferec; Marie Pierre Audrezet; Anita Laxova; Zhanhai Li; Michael R Kosorok; Marjorie A Rosenberg; William M Gershan
Journal:  J Cyst Fibros       Date:  2005-11-04       Impact factor: 5.482

9.  Progression of lung disease on computed tomography and pulmonary function tests in children and adults with cystic fibrosis.

Authors:  P A de Jong; A Lindblad; L Rubin; W C J Hop; J C de Jongste; M Brink; H A W M Tiddens
Journal:  Thorax       Date:  2005-10-21       Impact factor: 9.139

10.  A controlled trial of long-term inhaled hypertonic saline in patients with cystic fibrosis.

Authors:  Mark R Elkins; Michael Robinson; Barbara R Rose; Colin Harbour; Carmel P Moriarty; Guy B Marks; Elena G Belousova; Wei Xuan; Peter T P Bye
Journal:  N Engl J Med       Date:  2006-01-19       Impact factor: 91.245

View more
  21 in total

1.  Risk stratification model to detect early pulmonary disease in infants with cystic fibrosis diagnosed by newborn screening.

Authors:  Lacrecia J Britton; Gabriela R Oates; Robert A Oster; Staci T Self; Robert B Troxler; Wynton C Hoover; Hector H Gutierrez; William T Harris
Journal:  Pediatr Pulmonol       Date:  2016-08-24

2.  In utero and postnatal VX-770 administration rescues multiorgan disease in a ferret model of cystic fibrosis.

Authors:  Xingshen Sun; Yaling Yi; Ziying Yan; Bradley H Rosen; Bo Liang; Michael C Winter; T Idil Apak Evans; Pavana G Rotti; Yu Yang; Jaimie S Gray; Soo Yeun Park; Weihong Zhou; Yulong Zhang; Shashanna R Moll; Lisa Woody; Dao M Tran; Licong Jiang; Annelotte M Vonk; Jeffrey M Beekman; Paul Negulescu; Fred Van Goor; Dennis F Fiorino; Katherine N Gibson-Corley; John F Engelhardt
Journal:  Sci Transl Med       Date:  2019-03-27       Impact factor: 17.956

3.  Early life growth patterns persist for 12 years and impact pulmonary outcomes in cystic fibrosis.

Authors:  Don B Sanders; Zhumin Zhang; Philip M Farrell; HuiChuan J Lai
Journal:  J Cyst Fibros       Date:  2018-02-01       Impact factor: 5.482

4.  Pseudomonas aeruginosa in vitro phenotypes distinguish cystic fibrosis infection stages and outcomes.

Authors:  Nicole Mayer-Hamblett; Margaret Rosenfeld; Ronald L Gibson; Bonnie W Ramsey; Hemantha D Kulasekara; George Z Retsch-Bogart; Wayne Morgan; Daniel J Wolter; Christopher E Pope; Laura S Houston; Bridget R Kulasekara; Umer Khan; Jane L Burns; Samuel I Miller; Lucas R Hoffman
Journal:  Am J Respir Crit Care Med       Date:  2014-08-01       Impact factor: 21.405

5.  Longitudinal development of initial, chronic and mucoid Pseudomonas aeruginosa infection in young children with cystic fibrosis.

Authors:  S L Heltshe; U Khan; V Beckett; A Baines; J Emerson; D B Sanders; R L Gibson; W Morgan; M Rosenfeld
Journal:  J Cyst Fibros       Date:  2017-10-28       Impact factor: 5.482

6.  Impact of social complexity on outcomes in cystic fibrosis after transfer to adult care.

Authors:  Erin M Crowley; Gabriel T Bosslet; Babar Khan; Mary Ciccarelli; Cynthia D Brown
Journal:  Pediatr Pulmonol       Date:  2018-04-02

7.  Risk factors for lung function decline in a large cohort of young cystic fibrosis patients.

Authors:  Jonathan Cogen; Julia Emerson; Don B Sanders; Clement Ren; Michael S Schechter; Ronald L Gibson; Wayne Morgan; Margaret Rosenfeld
Journal:  Pediatr Pulmonol       Date:  2015-06-09

8.  Newborn screening alone insufficient to improve pulmonary outcomes for cystic fibrosis.

Authors:  Christina B Barreda; Philip M Farrell; Anita Laxova; Jens C Eickhoff; Andrew T Braun; Ryan J Coller; Michael J Rock
Journal:  J Cyst Fibros       Date:  2020-06-13       Impact factor: 5.482

9.  Lung inflammation and simulated airway resistance in infants with cystic fibrosis.

Authors:  Emily M DeBoer; Julia S Kimbell; Kaci Pickett; Joseph E Hatch; Kathryn Akers; John Brinton; Graham L Hall; Louise King; Fiona Ramanauskas; Tim Rosenow; Stephen M Stick; Harm A Tiddens; Thomas W Ferkol; Sarath C Ranganathan; Stephanie D Davis
Journal:  Respir Physiol Neurobiol       Date:  2021-06-19       Impact factor: 1.931

Review 10.  Quantification of Phenotypic Variability of Lung Disease in Children with Cystic Fibrosis.

Authors:  Mirjam Stahl; Eva Steinke; Marcus A Mall
Journal:  Genes (Basel)       Date:  2021-05-25       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.